NIH-funded research R01 grant

Understanding inflammaging in Down syndrome to improve immune health

Official title: Mechanistic and functional dissection of inflammaging in Down syndrome

Funded at Benaroya Research Inst at Virginia Mason · NIH-11391090 · Data updated 2026-11-12

This grant studies why people with Down syndrome age their immune system faster and how this affects infections, vaccines, and autoimmune problems, with the goal of new therapies.

More Down Syndrome research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBenaroya Research Inst at Virginia Mason
NIH-funded
Lab location1 site (Seattle, United States)
Project startSeptember 1, 2022
Project endAugust 31, 2027
Funding year2026
Award (this year)$677,851
NIH project number5R01AI166835-05
Project IDNIH-11391090 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with Down syndrome or related autoimmune features who could participate in immune profiling and translational studies.

Less likely to help

People without Down syndrome or without autoimmune or immune aging features may not directly benefit.

What this research studies

People with Down syndrome often show signs of an aging immune system, including more autoimmunity and fewer young immune cells. The project uses a novel, unbiased way to map immune networks in DS and measure how aging-like changes emerge early in life. It aims to uncover how dysregulated naïve CD4+ T cells contribute to immune aging and identify gene drivers on chromosome 21 that influence this process. The findings could lead to new therapies for DS and help identify who in the general population might benefit from similar approaches. The research is designed to translate insights into strategies that improve immune responses and reduce autoimmune risk.

Why it matters

Potential benefit: Could lead to therapies that normalize immune aging in Down syndrome and improve responses to infections and vaccines.

How similar studies have gone: Prior work has shown that immune aging features are present in DS and related autoimmune conditions, supporting the potential for meaningful impact.

Where this research is happening

  • Benaroya Research Inst at Virginia Mason
    Seattle, United States
    Active

Researchers

  • Principal investigator: Khor, Bernard — Benaroya Research Inst at Virginia Mason
  • Study coordinator: Khor, Bernard

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.